Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Loncar Cancer Immunotherapy ETF CNCR NASDAQ

NASDAQ Global Market • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Chart & Stats

Market Data
52-Week Range7.881-16.27
Volume3.08K
Avg Volume (30D)2.15K
Market Cap$7.04M
Beta (1Y)0.96
IPO Date2015-10-14
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS26922A8264

Price Chart

Track all markets on TradingView
CNCR
Loncar Cancer Immunotherapy ETF  ·  NASDAQ Global Market
Financial Services • Asset Management
7.88 52WK RANGE 16.27

People Also View

SBIO
SBIO
ALPS Medical Breakthroughs ETF
$56.67
+0.91%
 BBC
BBC
Virtus LifeSci Biotech Clinical Trials ETF
$45.98
+1.29%
 BBP
BBP
Virtus LifeSci Biotech Products ETF
$87.08
-0.06%
 BTEC
BTEC
Principal Healthcare Innovators ETF
$39.49
+1.02%
 CHNA
CHNA
Loncar China BioPharma ETF
$13.53
-0.07%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$166.79
+1.15%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$312.93
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message